TABLE 2.
Covariates | Estimate | 95% Confidence interval – lower limit | 95% Confidence interval – upper limit | p value |
---|---|---|---|---|
Time (years since baseline) | 0.019 | 0.017 | 0.020 | <0.0001 |
Sex (female) | −0.057 | −0.078 | −0.036 | 0.001 |
Education (years) | −0.002 | −0.005 | 0.002 | 0.310 |
Time in Study | −0.018 | −0.021 | −0.015 | <0.001 |
Clinical diagnosis | ||||
MCI a vs. NCI b | 0.018 | −0.008 | 0.043 | 0.170 |
Dementia vs. NCI | 0.032 | −0.006 | 0.058 | 0.015 |
Neuropathological Index (per 0.01) | 0.022 | −0.042 | 0.086 | 0.510 |
Time*Clinical diagnosis | ||||
Time*MCI | 0.005 | 0.003 | 0.008 | <0.0001 |
Time*Dementia | 0.020 | 0.018 | 0.023 | <0.0001 |
In this study of how changes in the degree of frailty affected the probability of a diagnosis of Alzheimer's dementia, we highlight two key findings: (1) frailty increased at a rate of approximately one deficit per year in a sample of older adults from retirement communities in the USA; and (2) people who ultimately developed MCI or Alzheimer's dementia became frailer more quickly than those who did not, regardless of their neuropathological burden. These results underscore the importance of addressing frailty to manage dementia risk.
Mild cognitive impairment.
No cognitive impairment.